HoJin Shin, BPharm, PhD

Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School
Boston, Massachusetts, United States

HoJin Shin, BPharm, M.Sc. is a Ph.D. candidate in Population Health Sciences at Harvard Graduate School of Arts and Sciences, concentrating on Pharmacoepidemiology. She graduated with a Bachelor of Pharmacy and a Master of Pharmacy degrees from Seoul National University (South Korea). She earned a Master of Science degree in Pharmacoepidemiology at Harvard T.H. Chan School of Public Health. Her doctoral dissertation focuses on evaluating drug utilization, and comparative effectiveness and safety of antidiabetic drugs in patients with type 2 diabetes mellitus, using administrative claims databases and electronic health records. Her research also involves investigating potential confounding due to unmeasured critical confounders in pharmacoepidemiological studies using real-world data.

I do not have any relevant financial / non-financial relationships with any proprietary interests.

Presentation(s):

• Predicting Treatment Effects of a New Drug in a Target Population Based on Randomized Controlled Trial Results

  Friday, August 26, 2022
  2:30 PM – 2:45 PM CEST